Skip to main content
Log in

Plasma endothelin-1 like immunoreactivity levels in neonates

  • Neonatology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

We attempted to determine the plasma endothelin-1-like immunoreactivity (ET-1) levels and to evaluate its physiological significance in 29 neonates: 5 with respiratory distress syndrome (RDS), 3 with transient tachypnoea of the newborn (TTN), 4 with neonatal asphyxia, 5 with bronchopulmonary dysplasia (BPD) following RDS, 7 healthy preterm infants and 5 healthy full-term infants. Plasma ET-1 levels in infants with RDS were significantly higher than those in healthy full-term infants through the 1st week of life. Plasma ET-1 levels in infants with neonatal asphyxia were high on the first 2 days of life and then gradually decreased to those of healthy full-term infants. Plasma levels in infants with TTN were the same as those in healthy full-term infants. Plasma ET-1 levels in infants with BPD were high when compared with those in healthy preterm infants during the first 2 months of life. This study showed that plasma levels were markedly elevated for a long time in the infants with respiratory distress. We speculate that plasma ET-1 may be a specific marker for pulmonary endothelium injury in infants with respiratory distress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BPD:

bronchopulmonary dysplasia

ET-1:

endothelin-1-like immunoreactivity

RDS:

respiratory distress syndrome

TFA:

trifluoroacetic acid

TTN:

transient tachypnoea

References

  1. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F (1989) Presence of immunoreactive endothelin in human plasma. FEBS Lett 245:164–166

    PubMed  Google Scholar 

  2. Ando K, Hirata Y, Takei Y, Kawakami M, Marumo F (1991) Endothelin-1-like immunoreactivity in human urine. Nephron 57:36–39

    PubMed  Google Scholar 

  3. Arant BS Jr (1981) Nonrenal factors influencing renal function during the perinatal period. Clin Perinatol 8:225–240

    PubMed  Google Scholar 

  4. Berma W Jr, Yabek SM, Dillon T, Burstein R (1982) Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. Pediatrics 70:708–711

    PubMed  Google Scholar 

  5. Brownlee JR, Beekman RH, Rosenthal A (1988) Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res 24: 186–190

    PubMed  Google Scholar 

  6. Hirata Y, Itoh K, Ando K, Endo M, Marumo F (1989) Plasma endothelin levels during surgery. N Engl J Med 14:1686

    Google Scholar 

  7. Isozaki-Fukuda Y, Kojima T, Hirata Y, Ono A, Sawaragi S, Sawaragi I, Kobayashi Y (1991) Plasma immunoreactive endothelin-1 concentration in human fetal blood: Its relation to aspyhxia. Pediatr Res 30:244–247

    PubMed  Google Scholar 

  8. Klaus MH, Fanaroff AA (1986) Care of the high risk neonate, 3rd edn. Saunders, Philadelphia, pp 410

    Google Scholar 

  9. Koch G, Wendel H (1968) Adjustment of arterial blood gases and acid base balance in the normal newborn infant during the first week of life. Biol Neonate 12:316–361

    Google Scholar 

  10. MacCumber MW, Ross CA, Glaser BM (1989) Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 86:7285–7289

    PubMed  Google Scholar 

  11. Madeddu P, Yang XP, Anania V, Troffa C (1990) Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin. Am J Physiol 259:F304–311

    PubMed  Google Scholar 

  12. Rakugi H, Tabuchi Y, Nakamaru M, Nagano M, Higashimori K, Mikami H, Ogihara T, Suzuki N (1990) Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 169:973–977

    Article  PubMed  Google Scholar 

  13. Shirakami G, Nakao K, Saito Y, Magaribuchi T (1991) Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci 48:969–976

    Article  PubMed  Google Scholar 

  14. Sobonya RE, Logvinoff MM, Taussig LM, Theriaut A (1982) Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia. Pediatr Res 16:969–972

    PubMed  Google Scholar 

  15. Suzuki N, Matsumoto, H, Kitada C, Kimura S, Miyauchi T, Fujino M (1990) A sandwich-type enzyme immunoassay to detect immunoreactive big-endothelin-1 in plasma. J Immunol Methods 127:165–170

    Article  PubMed  Google Scholar 

  16. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kojima, T., Isozaki-Fukuda, Y., Takedatsu, M. et al. Plasma endothelin-1 like immunoreactivity levels in neonates. Eur J Pediatr 151, 913–915 (1992). https://doi.org/10.1007/BF01954129

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01954129

Key words

Navigation